Cholesterol-induced hepatic inflammation does not contribute to the development of insulin resistance in male LDL receptor knockout mice
Anouk Funke(University Medical Center Groningen), Debby P.Y. Koonen(University Medical Center Groningen), Bart van de Sluis(University of Groningen), Nanda Gruben(University Medical Center Groningen), Fareeba Sheedfar(University of Groningen), Niels Kloosterhuis(University Medical Center Groningen), Marijke Schreurs(University Medical Center Groningen), Ronit Shiri‐Sverdlov(Maastricht University), Albert K. Groen(Amsterdam University Medical Centers), Marten H. Hofker(Maastricht University), Marcela Aparicio-Vergara(University Medical Center Groningen)
Cited by 23
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity
|Science|2016|2k
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2020|1.5k
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes
|Nature Genetics|2007|1.1k
The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids
|Circulation Research|2015|784